Increased Expression of the Neuronal Glutamate Transporter (EAAT3/EAAC1) in Hippocampal and Neocortical Epilepsy

• Published in: Epilepsia (Copenhagen) 2002-03, Vol.43 (3), p.211-218
• Main Authors: Crino, Peter B., Jin, Hong, Shumate, Melissa D., Robinson, Michael B., Coulter, Douglas A., Brooks‐Kayal, Amy R.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Amino Acid Transport System X-AG; Animals; Biological and medical sciences; Carrier Proteins - genetics; Carrier Proteins - metabolism; Cerebral Cortex - abnormalities; Cerebral Cortex - metabolism; Child; Dentate; Dentate Gyrus - metabolism; Dentate Gyrus - pathology; Dysplasia; EAAT3/EAAC1; Epilepsy; Epilepsy, Temporal Lobe - metabolism; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Female; Glutamate Plasma Membrane Transport Proteins; Glutamate transporter; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy; Hippocampus - metabolism; Humans; Immunohistochemistry; Male; Medical sciences; Neocortex - metabolism; Nervous system (semeiology, syndromes); Neurology; Neurons - metabolism; Rats; RNA, Messenger - metabolism; Symporters; Tissue Distribution
• ISSN: 0013-9580; 1528-1167
• DOI: 10.1046/j.1528-1157.2002.35001.x

Purpose: To define the changes in gene and protein expression of the neuronal glutamate transporter (EAAT3/EAAC1) in a rat model of temporal lobe epilepsy as well as in human hippocampal and neocortical epilepsy. Methods: The expression of EAAT3/EAAC1 mRNA was measured by reverse Northern blotting in single dissociated hippocampal dentate granule cells from rats with pilocarpine‐induced temporal lobe epilepsy (TLE) and age‐matched controls, in dentate granule cells from hippocampal surgical specimens from patients with TLE, and in dysplastic neurons microdissected from human focal cortical dysplasia specimens. Immunolabeling of rat and human hippocampi and cortical dysplasia tissue with EAAT3/EAAC1 antibodies served to corroborate the mRNA expression analysis. Results: The expression of EAAT3/EAAC1 mRNA was increased by nearly threefold in dentate granule cells from rats with spontaneous seizures compared with dentate granule cells from control rats. EAAT3/EAAC1 mRNA levels also were high in human dentate granule cells from patients with TLE and were significantly elevated in dysplastic neurons in cortical dysplasia compared with nondysplastic neurons from postmortem control tissue. No difference in expression of another glutamate transporter, EAAT2/GLT‐1, was observed. Immunolabeling demonstrated that EAAT3/EAAC1 protein expression was enhanced in dentate granule cells from both rats and humans with TLE as well as in dysplastic neurons from human cortical dysplasia tissue. Conclusions: Elevations of EAAT3/EAAC1 mRNA and protein levels are present in neurons from hippocampus and neocortex in both rats and humans with epilepsy. Upregulation of EAAT3/EAAC1 in hippocampal and neocortical epilepsy may be an important modulator of extracellular glutamate concentrations and may occur as a response to recurrent seizures in these cell types.